How YUTIQ Works: YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg

How YUTIQ Works

One injection, continuous calm with less inflammation

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg works inside your eye, delivering posterior segment uveitis treatment over time and directly where it’s needed. Your retina specialist, uveitis specialist, or other eye doctor will walk you through how YUTIQ works.

This close-up view shows the small size of the YUTIQ implant compared to a dime.

Tiny implant, lasting impact—With an implant (only 3.5 mm long) visible only to your eye doctor, YUTIQ releases medicine within the eye, and patients began seeing results as soon as 6 months after starting YUTIQ treatment.

Designed for the long term—YUTIQ is a tiny implant that is placed in the eye, designed to deliver a sustained release of medicine for up to 36 months.

What is the YUTIQ procedure? The eye is numbed and prepared, the implant is inserted with a tiny needle, and within 2 to 7 days you will have a follow-up appointment. A short procedure with lasting results, the YUTIQ implant is inserted while in the eye doctor’s office. It provides a low dose of steroid for up to 36 months. Talk with your retina or uveitis specialist about treatment with YUTIQ.

Don’t have a retina or uveitis specialist? Find one here.

Procedure expectations with YUTIQ

See YUTIQ patient stories

*People pictured are not real patients unless otherwise noted.

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ

YUTIQ may cause serious side effects, including:

Injection-related effects, steroid-related effects and movement of the implant.

Call your doctor if your eye becomes red, sensitive to light, painful or if your vision changes or becomes blurred.

You may experience temporary blurred vision. Do not drive or use machines until your vision clears.

The most common side effects in the eye were cataract and reduced clarity of vision. The most common side effects not related to the eye were upper respiratory infection, high blood pressure and joint pain.

If you are pregnant, become pregnant or consider breastfeeding after having received YUTIQ inform your doctor immediately.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

YUTIQ, the YUTIQ logo, and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. EyePoint Assist is a service mark of EyePoint Pharmaceuticals, Inc.

480 Pleasant Street, Suite B300, Watertown, MA 02472

12/2022

US-YUT-2200116

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ